Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPreclinical Probes for Oncology

Comparative analyses of the biodistribution of 89Zr-labeled human serum albumin in the mouse and HET-CAM model

Colmar Hilbrig, Jessica Loeffler, Gabriel Fischer, Hendrik Herrmann, Christoph Solbach, Markus Huber-Lang, Volker Rasche, Ambros Beer and Gordon Winter
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2887;
Colmar Hilbrig
1University Ulm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Loeffler
2Ulm University Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Fischer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Herrmann
3Department of Nuclear Medicine, University of Ulm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Solbach
4Uniklinik Ulm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Huber-Lang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Volker Rasche
5Department of Internal Medicine II, Ulm University Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ambros Beer
6Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Winter
7Department of Nuclear Medicine, Ulm University Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2887

Introduction: Evaluation of specific accumulation and biodistribution of novel radioligands is mostly performed in xenograft mouse models. Also, accumulation of compounds based on the EPR effect (Enhanced Permeability and Retention) is analyzed in these models. In accordance with the 3Rs principles (Replacement, Reduction, Refinement), this study focuses on the xenograft HET-CAM (Hen’s Egg Test - Chorioallantoic Membrane) model as a possible alternative for the analysis of intratumoral accumulation and retention in blood. For this purpose, biodistribution 89Zr-labeled human serum albumin is studied in the SCID mouse model as well as in the HET-CAM model using PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging)

Methods: The radioligand [89Zr]Zr-DFO-HSA was injected intravenously into SCID mice (n=5) and chicken embryos (n=4). Applied tumor types (TZM-bl/PC-3 or C4-2/PC-3) where either grafted to the subscapular region of the mice or in silicon rings onto the CAM. Dynamic PET scans and anatomic MR imaging were used to analyze distribution kinetics. Mice were analyzed over a period of 24h, while chick embryos were analyzed over a period of 1h. Accumulation in target tissues was quantified in ex vivo biodistribution analyses and possible intratumoral biodistribution of the ligand was verified by histological staining and autoradiography. PET data were analyzed in PMOD, and statistical analysis was performed using SPSS 28 and GraphPad Prism 9.3.1.

Results: Based on PET evaluations, an activity concentration of (31.8 ± 4.4) %IA/ml was detected in the blood of SCID mice and of (22.0 ± 7.4) %IA/ml in the blood of chick embryos after 1 hour of measurement. Simultaneously, an increase to (3.1 ± 0.9) %IA/ml in mice and to (2.8 ± 3.5) %IA/ml in the HET-CAM model was observed in PC-3 tumors within 60 minutes.

Similar kinetics were observed in mice and the HET-CAM model during the measurement period. Statistical analysis by comparing the kinetics of radioligands from mouse and HET-CAM model using linear regression revealed a strong significant correlation of the courses in blood (r=0.965, p<0.0001), but no significant correlation for PC-3 tumor (r=0.573; p=0.056).

When comparing the slopes of simple linear regression analyses (equivalent to accumulation over time) of the HET-CAM and mouse measurements, no statistically significant differences were detected for either blood or tumor kinetics.

Conclusions: Accumulation in tumor tissue and corresponding blood retention due to the EPR effect were demonstrated in both models. The strong significant correlation of the observed blood pool kinetics in both mice and HET-CAM xenograft systems suggest similar distribution and resorption characteristics of the radiolabeled HSA. Thus, the HET-CAM model may represents a potential alternative to the mouse model, not only regarding aspects of simpler handling and lower maintenance costs, but also in terms of the 3Rs principles.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparative analyses of the biodistribution of 89Zr-labeled human serum albumin in the mouse and HET-CAM model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparative analyses of the biodistribution of 89Zr-labeled human serum albumin in the mouse and HET-CAM model
Colmar Hilbrig, Jessica Loeffler, Gabriel Fischer, Hendrik Herrmann, Christoph Solbach, Markus Huber-Lang, Volker Rasche, Ambros Beer, Gordon Winter
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2887;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparative analyses of the biodistribution of 89Zr-labeled human serum albumin in the mouse and HET-CAM model
Colmar Hilbrig, Jessica Loeffler, Gabriel Fischer, Hendrik Herrmann, Christoph Solbach, Markus Huber-Lang, Volker Rasche, Ambros Beer, Gordon Winter
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2887;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • TAM Targeted Imaging Agents Binding CD206 and Selective Blocking of Off Target Liver Localization
  • A Novel approach for ovarian cancer detection
  • Formulation and preclinical analysis of 68Ga/177Lu/225Ac labeled αvβ3-integrin targeting peptidomimetic (IAC) for PET Imaging and targeted radionuclide therapy
Show more Preclinical Probes for Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire